Julie Xing
Director/Board Member bij APTARGROUP, INC.
Vermogen: 387 927 $ op 31-03-2024
Profiel
Julie Xing is currently the Executive Chairman at Mundipharma (China) Pharmaceutical Co., Ltd.
and an Independent Director at AptarGroup, Inc. She previously worked at Eli Lilly & Co. as the Senior Director-Global New Product Planning from 2010 to 2019.
Julie also held positions at Panomics LLC as the VP, GM-Asia Pacific & Japan Operations, and at Envista Holdings Corp.
as the Global Senior VP & President-Greater China.
She holds a doctorate degree from The Hong Kong University of Science & Technology.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
APTARGROUP, INC.
0.00% | 01-05-2024 | 2 696 ( 0.00% ) | 387 927 $ | 31-03-2024 |
Actieve functies van Julie Xing
| Bedrijven | Functie | Begin |
|---|---|---|
| APTARGROUP, INC. | Director/Board Member | 01-03-2023 |
Mundipharma (China) Pharmaceutical Co., Ltd.
 Mundipharma (China) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Mundipharma International Ltd., Mundipharma (China) Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Beijing, China. | Chairman | 01-03-2023 |
Eerdere bekende functies van Julie Xing
| Bedrijven | Functie | Einde |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-01-2019 |
Panomics LLC
 Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Corporate Officer/Principal | - |
| ENVISTA HOLDINGS CORPORATION | Corporate Officer/Principal | - |
Opleiding van Julie Xing
| The Hong Kong University of Science & Technology | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| APTARGROUP, INC. | Process Industries |
| ELI LILLY AND COMPANY | Health Technology |
| ENVISTA HOLDINGS CORPORATION | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Panomics LLC
Panomics LLC Miscellaneous Commercial ServicesCommercial Services Panomics LLC provides life sciences research reagents. It develops products and technologies for Parallel Quantitative Biology, a platform of reagents and products that enable the multiplex measurement of molecular events, such as intracellular pathway analysis, cell signaling and gene expression profiling, in a quantitative and scalable manner. The company was founded in 2000 and is headquartered in Fremont, CA. | Commercial Services |
Mundipharma (China) Pharmaceutical Co., Ltd.
Mundipharma (China) Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Mundipharma International Ltd., Mundipharma (China) Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The private company is based in Beijing, China. | Health Technology |
